DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Raymond James Maintains Outperform on ZIOPHARM Oncology, Lowers Price Target to $5.5

Raymond James maintains ZIOPHARM Oncology (NASDAQ:ZIOP) with a Outperform and lowers the price target from $6.5 to $5.5.

Benzinga · 03/03/2020 12:34

Raymond James maintains ZIOPHARM Oncology (NASDAQ:ZIOP) with a Outperform and lowers the price target from $6.5 to $5.5.